Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Selenium, zinc, and vitamin D supplementation affect the clinical course of COVID-19 infection in Hashimoto’s thyroiditis

Asimi et al., Endocrine Abstracts, doi:10.1530/endoabs.73.PEP14.2
May 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ventilation 97% Improvement Relative Risk Hospitalization 99% Severe case 100% Vitamin D for COVID-19  Asimi et al.  EARLY TREATMENT Is early treatment with vitamin D + zinc and selenium beneficial for COVID-19? Retrospective 356 patients in Bosnia and Herzegovina Lower ventilation (p<0.0001) and hospitalization (p<0.0001) c19early.org Asimi et al., Endocrine Abstracts, May 2021 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
Retrospective 356 Hashimoto's thyroiditis outpatients, 270 taking vitamin D, zinc, and selenium, showing significantly lower hospitalization with treatment. Authors adjust for age, gender, BMI, and smoking status, reporting statistically significant associations with p<0.001 for hospitalization and mechanical ventilation, however they do not report the adjusted risks.
This is the 37th of 122 COVID-19 controlled studies for vitamin D, which collectively show efficacy with p<0.0000000001 (1 in 587 sextillion).
30 studies are RCTs, which show efficacy with p=0.0000032.
This study is excluded in the after exclusion results of meta analysis: excessive unadjusted differences between groups.
Study covers selenium, zinc, and vitamin D.
risk of mechanical ventilation, 97.4% lower, RR 0.03, p < 0.001, treatment 0 of 270 (0.0%), control 9 of 86 (10.5%), NNT 9.6, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), unadjusted.
risk of hospitalization, 99.0% lower, RR 0.010, p < 0.001, treatment 0 of 270 (0.0%), control 24 of 86 (27.9%), NNT 3.6, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), unadjusted.
risk of severe case, 99.5% lower, RR 0.005, p < 0.001, treatment 0 of 270 (0.0%), control 51 of 86 (59.3%), NNT 1.7, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), unadjusted.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Asimi et al., 22 May 2021, retrospective, Bosnia and Herzegovina, preprint, 3 authors, dosage 2,000IU daily, this trial uses multiple treatments in the treatment arm (combined with zinc and selenium) - results of individual treatments may vary.
This PaperVitamin DAll
Abstract: See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/351652823 Selenium, zinc, and vitamin D supplementation affect the clinical course of COVID-19 infection in Hashimoto s thyroiditis Article in Endocrine Abstracts · May 2021 DOI: 10.1530/endoabs.73.PEP14.2 CITATION READS 1 650 3 authors: Zelija Velija Asimi Almira Hadžović-Džuvo Sarajevo School of Science and Technology, Medical school University of Sarajevo 53 PUBLICATIONS 342 CITATIONS 70 PUBLICATIONS 341 CITATIONS SEE PROFILE SEE PROFILE Djinan Al-Tawil Policlic and daily hospital dr.Al-Tawil 3 PUBLICATIONS 2 CITATIONS SEE PROFILE Some of the authors of this publication are also working on these related projects: PUBLIC HEALTH IN THE WESTERN BALKANS – IMPROVEMENT IN THE FIELD OF PUBLIC HEALTH AND DEVELOPMENT OF A “ONE HEALTH” EDUCATIONAL AND SCIENTIFIC ARCHITECTURE IN WESTERN BALKAN COUNTRIES (project ID: EACEA-544182: 544182-TEMPUS-1-2013-1-IT-TEMPUS-JPCR) View project Genetic factors of thromborhilia in pregnancy loss, Crohn disease View project All content following this page was uploaded by Zelija Velija Asimi on 23 May 2021. The user has requested enhancement of the PEP14.2 Selenium, zinc, and vitamin D supplementation affect the clinical course of COVID-19 infection in Hashimoto's thyroiditis Zelija Velija Asimi1,2, Almira Hadzovic-Dzuvo1,3, Djinan Al-Tawil1 1Outpatient Clinic with a Daily hospital "Dr Al Tawil", Sarajevo, 2Sarajevo Medical School, SSST University, 3Sarajevo University, Bosnia and Herzegovina Adequate supply of zinc, selenium, and vitamin D is essential for resistance to other viral infections, immune function, and reduced inflammation. Low levels of micronutrients are associated with adverse clinical outcomes during viral infections. Vitamin D improves the physical barrier against the virus and stimulates the production of antimicrobial peptides. It can prevent cytokine storms by reducing the production of inflammatory cytokines. Selenium enhances the function of cytotoxic effector cells. Furthermore, selenium is important for maintaining T cell maturation and function, as well as for producing T cell-dependent antibodies. Our goal was to determine the effects of selenium, zinc, and vitamin D supplementation on recovery from COVID-19 in patients with pre-existing Hashimoto’s thyroiditis. CONCLUSION For the treatment of people with Hashimoto’s thyroiditis who become infected with COVID-19, the addition of selenium, zinc, and vitamin D3 could be beneficial. Randomized controlled trials and large population studies should be performed to evaluate these recommendations. Reference: 1. Alexander J, Tinkov A, Strand TA, Alehagen U, Skalny A, Aaseth J. Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19. Nutrients. 2020 Aug 7;12(8):2358. doi: 10.3390/nu12082358. PMID: 32784601; PMCID: PMC7468884. 2. Bae M, Kim H. Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19. Molecules. 2020 Nov 16;25(22):5346. doi: 10.3390/molecules25225346 3. Im JH, Je YS, Baek J, Chung MH, Kwon HY, Lee JS. Nutritional status of patients with COVID-19. Int J Infect Dis. 2020 Nov;100:390-393. doi: 10.1016/j.ijid.2020.08.018. Epub 2020 Aug 11. 4. Heller RA, Sun Q, Hackler J, Seelig J, Seibert L, Cherkezov A, Minich WB, Seemann P, Diegmann J, Pilz M, Bachmann M, Ranjbar A,..
{ 'indexed': {'date-parts': [[2022, 7, 14]], 'date-time': '2022-07-14T11:41:42Z', 'timestamp': 1657798902062}, 'reference-count': 0, 'publisher': 'Bioscientifica', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'DOI': '10.1530/endoabs.73.pep14.2', 'type': 'journal-article', 'created': {'date-parts': [[2021, 5, 17]], 'date-time': '2021-05-17T13:19:11Z', 'timestamp': 1621257551000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Selenium, zinc, and vitamin D supplementation affect the clinical course of COVID-19 infection ' 'in Hashimoto\x92s thyroiditis', 'prefix': '10.1530', 'author': [ {'given': 'Asimi Zelija', 'family': 'Velija', 'sequence': 'first', 'affiliation': []}, {'given': 'Hadzovic-Dzuv', 'family': 'Almira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tawil Djinan', 'family': 'Al', 'sequence': 'additional', 'affiliation': []}], 'member': '416', 'published-online': {'date-parts': [[2021, 5, 15]]}, 'container-title': 'Endocrine Abstracts', 'original-title': [], 'link': [ { 'URL': 'http://www.endocrine-abstracts.org/ea/0073/ea0073pep14.2.htm', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 7, 14]], 'date-time': '2022-07-14T01:48:24Z', 'timestamp': 1657763304000}, 'score': 1, 'resource': {'primary': {'URL': 'http://www.endocrine-abstracts.org/ea/0073/ea0073pep14.2.htm'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 5, 15]]}, 'references-count': 0, 'URL': 'http://dx.doi.org/10.1530/endoabs.73.PEP14.2', 'relation': {}, 'ISSN': ['1479-6848'], 'subject': ['General Medicine'], 'container-title-short': 'EJEA', 'published': {'date-parts': [[2021, 5, 15]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit